Research focus
About the research
Which genetic changes drive prostate cancer, and how can they be turned into tests and treatments for patients?
Read the full research overview
Researchers in the group uncovered gene fusions joining TMPRSS2 with ETS family genes in most prostate cancers, the first causative fusion found in a common solid tumor. A clinical sequencing program called MI-Oncoseq profiles tumors from advanced cancer patients to support precision oncology decisions. Prostate cancer biomarkers characterized by the team include AMACR, EZH2, a sarcosine metabolite, and the long non-coding RNA Schlap1. A large part of the laboratory applies RNA sequencing to map long non-coding RNAs in cancer, including detailed studies of PCAT1, PCAT29 and PCA3.
Selected publications
3 listedLiver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Nature Medicine
A proteogenomic portrait of lung squamous cell carcinoma
Cell
Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response
Proceedings of the National Academy of Sciences
People & alumni
Team details haven’t been added. See the lab’s website for its current members.
Alumni details haven’t been added. Check the lab’s official website.
Sources & listing information
Find Research Labs maintains this page using public sources. The faculty member, lab, and university have not claimed or approved this listing. Listing a lab does not indicate endorsement, partnership, or a recruiting opportunity.
Request a correction or removal ↗ · About directory listings